Photodynamic therapy In photodynamic therapy (PDT), a photosensitising drug is applied to the treatment site and subsequently activated by visible light (see Figure 2)
Disclaimer: The information provided in this article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment
All statistical analyses were conducted on the TriNetX platform on (accessed date 31 March 2024, 23:35:21 UTC)
In Italy, as in many other countries, a specific KDT transition program is not available
Human gut microbiome adopts an alternative state following small bowel transplantation
Potential areas of expansion include: Cardiovascular outcomes: A dedicated CVOT, if not already required as a post-marketing commitment, would evaluate whether orforglipron reduces MACE in patients with established cardiovascular disease or high cardiovascular risk, following the precedent set by the SELECT trial for semaglutide